ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,654, issued on Aug. 18, was assigned to Abalos Therapeutics GmbH (Dusseldorf, Germany).
"Virus particles for therapeutic purposes" was invented by Jorg Vollmer (Dusseldorf, Germany), Marcus Kostka (Dusseldorf, Germany), Philipp Lang (Dusseldorf, Germany) and Haifeng Xu (Dusseldorf, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a virus particle comprising a lymphocytic choriomeningitis virus (LCMV) S segment and an LCMV L segment, wherein the S segment comprises an open reading frame encoding a glycoprotein derived from LCMV strain WE, and wherein the L segment comprises an open reading frame encoding an L protein de...